Longtime liberal advocate to lead generics industry group

The Generic Pharmaceutical Association is about to get a new lead lobbyist: Ralph Neas, whom the New York Times characterizes as "a longtime advocate for liberal causes." Neas told the Times he's "anxious to tell" policy makers about the generics industry's efforts in controlling healthcare costs. Report

Suggested Articles

An online pharmacy has again criticized FDA action after tipping off regulators to the existence of a dangerous impurity in Zantac and other antacids.

A group of senators is asking the FTC to take a careful look at pharma mergers given the cost of drugs in the U.S.

Life’s been tough for J&J's prostate cancer med Erleada in its battle with Pfizer-Astellas’ Xtandi. A new FDA nod could help level the playing field.…